Pidotimod
- Generic Name
- Pidotimod
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H12N2O4S
- CAS Number
- 121808-62-6
- Unique Ingredient Identifier
- 785363R681
- Background
Pidotimod is a synthetic dipeptide with immunomodulatory properties.
- Indication
For use as immunostimulant therapy for treatment of cell-mediated immunosuppression with respiratory or urinary infections .
- Associated Conditions
- Recurrent Upper Respiratory Tract Infections
- Associated Therapies
- Immunostimulation
Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI)
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-03-26
- Last Posted Date
- 2022-02-02
- Lead Sponsor
- Almirall, S.A.
- Target Recruit Count
- 338
- Registration Number
- NCT04322669
- Locations
- 🇨🇳
Investigator Site 01 Children's Hospital Captial Institute of Pediatrics, Beijing, China
🇨🇳Investigator Site 16, Changchun, China
🇨🇳Investigator Site 03, Nanjing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath